Title:
C型肝炎トリペプチド阻害剤
Document Type and Number:
Japanese Patent JP2004538251
Kind Code:
A
Abstract:
The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
Inventors:
Jeffrey Allen Campbell
Andrew Good
Andrew Good
Application Number:
JP2002561494A
Publication Date:
December 24, 2004
Filing Date:
November 20, 2001
Export Citation:
Assignee:
BRISTOL-MYERS SQUIBB COMPANY
International Classes:
A61K38/00; A61P1/16; A61P31/12; A61P31/14; A61P43/00; C07K5/08; C12N9/99; C07K5/083; C07K5/087; (IPC1-7): C07K5/083; A61K38/00; A61P1/16; A61P31/12; A61P43/00
Attorney, Agent or Firm:
Mitsuo Tanaka
Misako Ohsaku
Nagatoshi Shinagawa
Misako Ohsaku
Nagatoshi Shinagawa